These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3291305)

  • 1. Usefulness of fractional excretion of sodium as index of cyclosporine nephrotoxicity in renal transplantation.
    Morales JM; Andres A; Alcazar JM; Prieto C; Diaz de Tueste I; Ruilope LM; Rodicio JL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):691-9. PubMed ID: 3291305
    [No Abstract]   [Full Text] [Related]  

  • 2. Fractional excretion of sodium represents an index of cyclosporine nephrotoxicity in the early post-transplant period.
    Morales JM; Andres A; Prieto C; Ruilope LM; Alcazar JM; Oliet A; Praga M; Rodicio JL
    Transplant Proc; 1987 Oct; 19(5):4005-7. PubMed ID: 3313985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicity.
    Vincent HH; Wenting GJ; Schalekamp MA; Jeekel J; Weimar W
    Transplant Proc; 1987 Oct; 19(5):4147-8. PubMed ID: 3314004
    [No Abstract]   [Full Text] [Related]  

  • 4. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 5. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
    Quarto Di Palo F; Elli A; Rivolta R; Parenti M; Palazzi P; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):969-71. PubMed ID: 1989347
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of ultrasound in the diagnosis of cyclosporine toxicity in renal transplantation.
    Bergren CT; Toledo-Pereyra LH; Craig BM; Fawcett KJ
    Bol Asoc Med P R; 1986 Feb; 78(2):50-4. PubMed ID: 3518734
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Adv Nephrol Necker Hosp; 1988; 17():303-20. PubMed ID: 3124545
    [No Abstract]   [Full Text] [Related]  

  • 10. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine.
    Thompson JF; Chalmers DH; Hunnisett AG; Wood RF; Morris PJ
    Transplantation; 1983 Aug; 36(2):204-6. PubMed ID: 6349046
    [No Abstract]   [Full Text] [Related]  

  • 12. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 13. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
    Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary exfoliative cytology in kidney allografts under cyclosporine therapy.
    Cortesini R; Stella F; Renna Molajoni E; Lemeni AR; Rossi M; Pretagostini R; Alfani D
    Transplant Proc; 1984 Oct; 16(5):1200-1. PubMed ID: 6385377
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of laboratory tests for differential diagnosis of acute renal allograft rejection and acute cyclosporine nephrotoxicity].
    Simić-Ogrizović S; Djukanović Lj; Golubović M; DimitrijevićZ ; Mimić-Oka J; Simić T
    Srp Arh Celok Lek; 1994; 122(5-6):133-6. PubMed ID: 17977408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical summation. An algorithm for the management of patients with cyclosporine-induced renal dysfunction.
    Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):303-8. PubMed ID: 3895669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.